Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short versus standard postoperative intravenous antibiotics for complex acute appendicitis
NL-OMON24288Phase 4Active, not recruiting
- Sponsor
- Heelkunde Instituut Nederland
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of cefuroxime, metronidazole and ceftriaxone in acute appendicitis (2 arms), sponsored by Heelkunde Instituut Nederland. Primary endpoint: Composite of mortality and infectious complications related to appendectomy. Started Jun 2017; status: active, not recruiting.
02
Drugs
cefuroximemetronidazoleceftriaxone
03
Conditions
acute appendicitis
Beyond the preview
Go deeper on NL-OMON24288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24288.